Indication
Finerenone
2 clinical trials
3 products
Clinical trial
Study on the Clinical Efficacy and Safety of the New Mineralocorticoid Receptor Antagonist Finerenone in the Treatment of Primary Aldosteronism: a Multicenter, Prospective, Open-label Clinical StudyStatus: Recruiting, Estimated PCD: 2027-03-01
Product
FinerenoneClinical trial
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGAStatus: Completed, Estimated PCD: 2024-03-31
Product
RAS inhibitorProduct
Immune Suppressant